Matrix Metalloproteinase 2
"Matrix Metalloproteinase 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A secreted endopeptidase homologous with INTERSTITIAL COLLAGENASE, but which possesses an additional fibronectin-like domain.
| Descriptor ID |
D020778
|
| MeSH Number(s) |
D08.811.277.656.300.480.205.352 D08.811.277.656.300.480.252.420 D08.811.277.656.300.480.525.700.150 D08.811.277.656.675.374.205.352 D08.811.277.656.675.374.252.420 D08.811.277.656.675.374.525.700.150 D12.644.276.848.150 D12.776.467.836.150
|
| Concept/Terms |
Matrix Metalloproteinase 2- Matrix Metalloproteinase 2
- Metalloproteinase 2, Matrix
- 72-kDa Gelatinase
- 72 kDa Gelatinase
- Gelatinase, 72-kDa
- 72-kDa Type IV Collagenase
- 72 kDa Type IV Collagenase
- MMP-2 Metalloproteinase
- MMP 2 Metalloproteinase
- Metalloproteinase, MMP-2
- Gelatinase A
- MMP2 Metalloproteinase
- Metalloproteinase, MMP2
- Matrix Metalloproteinase-2
|
Below are MeSH descriptors whose meaning is more general than "Matrix Metalloproteinase 2".
Below are MeSH descriptors whose meaning is more specific than "Matrix Metalloproteinase 2".
This graph shows the total number of publications written about "Matrix Metalloproteinase 2" by people in this website by year, and whether "Matrix Metalloproteinase 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 2 | 2 |
| 2006 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2016 | 0 | 5 | 5 |
| 2017 | 8 | 11 | 19 |
| 2018 | 3 | 11 | 14 |
| 2019 | 2 | 3 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Matrix Metalloproteinase 2" by people in Profiles.
-
MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patients. Biomed Pharmacother. 2021 Oct; 142:112067.
-
MMP2/MMP9-mediated CD100 shedding is crucial for inducing intrahepatic anti-HBV CD8 T cell responses and HBV clearance. J Hepatol. 2019 10; 71(4):685-698.
-
Fatty Acid Desaturase Involvement in Non-Alcoholic Fatty Liver Disease Rat Models: Oxidative Stress Versus Metalloproteinases. Nutrients. 2019 Apr 08; 11(4).
-
TLR4 blockade using TAK-242 suppresses ovarian and breast cancer cells invasion through the inhibition of extracellular matrix degradation and epithelial-mesenchymal transition. Eur J Pharmacol. 2019 Jun 15; 853:256-263.
-
Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress. Can J Gastroenterol Hepatol. 2019; 2019:5413461.
-
Stanniocalcin-1 promotes cell proliferation, chemoresistance and metastasis in hypoxic gastric cancer cells via Bcl-2. Oncol Rep. 2019 Mar; 41(3):1998-2008.
-
Monitoring treatment response in patients affected by actinic keratosis: Dermoscopic assessment and metalloproteinases evaluation after piroxicam 0.8% and sunfilter cream. Dermatol Ther. 2019 01; 32(1):e12772.
-
Toll-Like Receptor 4 (TLR4)/Cyclooxygenase-2 (COX-2) Regulates Prostate Cancer Cell Proliferation, Migration, and Invasion by NF-?B Activation. Med Sci Monit. 2018 Aug 11; 24:5588-5597.
-
Heat shock protein 47 as indispensible participant in liver fibrosis: Possible protective effect of lactoferrin. IUBMB Life. 2018 08; 70(8):795-805.
-
Nisin, a potent bacteriocin and anti-bacterial peptide, attenuates expression of metastatic genes in colorectal cancer cell lines. Microb Pathog. 2018 Oct; 123:183-189.